InvestorsHub Logo
Followers 32
Posts 2793
Boards Moderated 3
Alias Born 10/24/2015

Re: None

Sunday, 04/30/2023 1:26:22 PM

Sunday, April 30, 2023 1:26:22 PM

Post# of 76
ASCO

Safety and efficacy of obecabtagene autoleucel (obe-cel, AUTO1), a fast-off rate CD19 CAR, in relapsed/refractory adult B-cell acute lymphoblastic leukemia (r/r B-ALL): Top line results of the pivotal FELIX study https://meetings.asco.org/abstracts-presentations/219864
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUTL News